Gilead Sciences (GILD) Enterprise Value (2009 - 2026)
Gilead Sciences posted quarterly Enterprise Value of -$7.7 billion for Q1 2026, up 3.53% year-on-year from -$7.5 billion in Q1 2025, and little changed on a QoQ basis from -$7.7 billion in Q4 2025.
Gilead Sciences (GILD) has 18 years of Enterprise Value data on file, last reported at -$7.7 billion in Q1 2026.
- For the quarter ending Q1 2026, Enterprise Value rose 3.53% year-over-year to -$7.7 billion; the trailing twelve-month figure through Mar 2026 stood at -$7.7 billion (up 3.53% YoY), and the FY2025 full-year result was -$7.7 billion, up 23.41% from the prior year.
- Enterprise Value for Q1 2026 stood at -$7.7 billion, roughly flat from -$7.7 billion in the prior quarter.
- Across five years, Enterprise Value topped out at -$2.9 billion in Q2 2024 and bottomed at -$10.1 billion in Q4 2024.
- The 5-year median for Enterprise Value is -$6.4 billion (2022), against an average of -$6.4 billion.
- The widest annual swing landed in 2024, when Enterprise Value surged 57.57%; it then sank 85.47% in 2025.
- A 5-year view of Enterprise Value shows it stood at -$6.4 billion in 2022, then retreated by 14.53% to -$7.3 billion in 2023, then sank by 37.11% to -$10.1 billion in 2024, then increased by 23.41% to -$7.7 billion in 2025, then dropped by 0.14% to -$7.7 billion in 2026.
- The last three Enterprise Value figures came in at -$7.7 billion (Q1 2026), -$7.7 billion (Q4 2025), and -$7.4 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn | -5.28 Bn |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn | -22.05 Bn |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn | -9.35 Bn |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn | -5.65 Bn |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn | -12.04 Bn |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn | -7.73 Bn |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn | -12.77 Bn |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn | -10.45 Bn |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - | -4.68 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7.73 Bn |
| Dec 31, 2025 | -7.72 Bn |
| Sep 30, 2025 | -7.43 Bn |
| Jun 30, 2025 | -5.30 Bn |
| Mar 31, 2025 | -8.01 Bn |
| Dec 31, 2024 | -10.08 Bn |
| Sep 30, 2024 | -5.12 Bn |
| Jun 30, 2024 | -2.86 Bn |
| Mar 31, 2024 | -4.80 Bn |
| Dec 31, 2023 | -7.35 Bn |
| Sep 30, 2023 | -6.94 Bn |
| Jun 30, 2023 | -6.73 Bn |
| Mar 31, 2023 | -5.93 Bn |
| Dec 31, 2022 | -6.42 Bn |
| Sep 30, 2022 | -5.68 Bn |
| Jun 30, 2022 | -5.68 Bn |
| Mar 31, 2022 | -5.34 Bn |
| Dec 31, 2021 | -6.53 Bn |
| Sep 30, 2021 | -5.74 Bn |
| Jun 30, 2021 | -6.52 Bn |
| Mar 31, 2021 | -5.65 Bn |
| Dec 31, 2020 | -7.39 Bn |
| Sep 30, 2020 | -23.95 Bn |
| Jun 30, 2020 | -18.80 Bn |
| Mar 31, 2020 | -20.67 Bn |
| Dec 31, 2019 | -24.23 Bn |
| Sep 30, 2019 | -22.72 Bn |
| Jun 30, 2019 | -27.05 Bn |
| Mar 31, 2019 | -27.76 Bn |
| Dec 31, 2018 | -29.94 Bn |
| Sep 30, 2018 | -28.32 Bn |
| Jun 30, 2018 | -25.86 Bn |
| Mar 31, 2018 | -23.94 Bn |
| Dec 31, 2017 | -25.45 Bn |
| Sep 30, 2017 | -27.98 Bn |
| Jun 30, 2017 | -20.68 Bn |
| Mar 31, 2017 | -13.64 Bn |
| Dec 31, 2016 | -11.42 Bn |
| Sep 30, 2016 | -11.77 Bn |
| Jun 30, 2016 | -8.17 Bn |
| Mar 31, 2016 | -7.70 Bn |
| Dec 31, 2015 | -14.03 Bn |
| Sep 30, 2015 | -15.18 Bn |
| Jun 30, 2015 | -8.26 Bn |
| Mar 31, 2015 | -10.89 Bn |
| Dec 31, 2014 | -9.74 Bn |
| Sep 30, 2014 | -6.02 Bn |
| Jun 30, 2014 | -8.46 Bn |
| Mar 31, 2014 | -6.15 Bn |
| Dec 31, 2013 | -1.76 Bn |
| Sep 30, 2013 | -1.78 Bn |
| Jun 30, 2013 | -2.04 Bn |
| Mar 31, 2013 | -1.70 Bn |
| Dec 31, 2012 | -1.62 Bn |
| Sep 30, 2012 | -1.55 Bn |
| Jun 30, 2012 | -1.63 Bn |
| Mar 31, 2012 | -1.40 Bn |
| Dec 31, 2011 | -9.77 Bn |
| Sep 30, 2011 | -2.14 Bn |
| Jun 30, 2011 | -2.11 Bn |
| Mar 31, 2011 | -2.78 Bn |
| Dec 31, 2010 | -1.84 Bn |
| Sep 30, 2010 | -2.14 Bn |
| Jun 30, 2010 | -1.48 Bn |
| Mar 31, 2010 | -1.49 Bn |
| Dec 31, 2009 | -1.52 Bn |
| Sep 30, 2009 | -1.25 Bn |
| Jun 30, 2009 | -1.12 Bn |
| Mar 31, 2009 | -1.66 Bn |